TAKEDA PHARMACEUTICAL CO LTD - 04 Nov 2021 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: 10%+ Owner
Signature: /s/ Amit Singh, Senior Vice President and Head of Treasury of Takeda Pharmaceutical Company Limited
Issuer symbol: PHAT
Transactions as of: 04 Nov 2021
Net transactions value: -$20,850,019
Form type: 4
Filing time: 08 Nov 2021, 05:04:00 UTC
Previous filing: 26 Oct 2021
Next filing: 29 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHAT	Common Stock	Exercise of in-the-money or at-the-money derivative security	$0	+228,696	+26%	$0.000000	1,100,001	04 Nov 2021	Direct	F1
transaction	PHAT	Common Stock	Sale	$19	-1	-0%	$19.00	1,100,000	04 Nov 2021	Direct	F1
transaction	PHAT	Common Stock	Sale	$20,850,000	-1,000,000	-91%	$20.85	100,000	04 Nov 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PHAT	Warrants	Exercise of in-the-money or at-the-money derivative security	$0	-228,696	-3%	$0.000000	7,359,304	04 Nov 2021	Common Stock	228,696	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On November 4, 2021, the Reporting Person exercised a Warrant to purchase 228,696 shares of the Issuers common stock with an exercise price of $0.00004613 per share. The Reporting Person paid the exercise price on a cashless basis in accordance with the terms of such Warrants, resulting in the Issuer withholding a number of shares (or portion thereof) to satisfy the exercise price and issuing to the Reporting Person the remaining number of shares. The Issuer also paid the Reporting Person $8.45 in lieu of a fractional share.

Content

On November 4, 2021, the Reporting Person exercised a Warrant to purchase 228,696 shares of the Issuers common stock with an exercise price of $0.00004613 per share. The Reporting Person paid the exercise price on a cashless basis in accordance with the terms of such Warrants, resulting in the Issuer withholding a number of shares (or portion thereof) to satisfy the exercise price and issuing to the Reporting Person the remaining number of shares. The Issuer also paid the Reporting Person $8.45 in lieu of a fractional share.